#USA #New York #Rosen Law Firm #TNDM #Tandem Diabetes

Rosen Law Firm Investigation into Tandem Diabetes Care

The Rosen Law Firm, an internationally recognized firm dedicated to protecting investor rights, is currently investigating potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM). This comes after allegations that the company may have provided materially misleading information regarding its business practices, which has raised concerns among investors.

What Triggered the Investigation?

On August 7, 2025, Tandem Diabetes released a press statement regarding a voluntary medical device correction for selected tslim X2 insulin pumps. The statement addressed critical safety issues related to the devices, specifically a potential speaker-related problem that could lead to a disruption in insulin delivery. This announcement had an immediate and adverse effect on the company's stock, causing it to plummet by nearly 20% on the same day.

Understanding Your Rights as an Investor

For individuals who purchased Tandem Diabetes securities and may have been impacted by these developments, the Rosen Law Firm is providing an opportunity for potential compensation through a class action lawsuit. Thanks to a contingency fee arrangement, affected investors can pursue financial recovery without any upfront costs. This legal approach ensures that if the case does not succeed, there will be no out-of-pocket expenses for those involved.

How to Get Involved

If you believe you qualify for participation in this class action suit, it's crucial to act quickly. Interested parties can visit the Rosen Law Firm's dedicated website to submit their information. Alternatively, you can contact Phillip Kim, an attorney at the firm, toll-free at 866-767-3653, or reach out via email at [email protected]. The firm is focused on gathering necessary details to include affected investors in the forthcoming litigation.

Why Choose Rosen Law Firm?

Choosing the right legal representation is vital in securities class actions. The Rosen Law Firm boasts an impressive history of successful outcomes, including being recognized as the top firm for securities class action settlements by ISS Securities Class Action Services. In 2019 alone, the firm secured over $438 million for its clients, showcasing their commitment and success in handling complex cases in this field. Furthermore, the firm has been acknowledged by peer entities, including Lawdragon and Super Lawyers, underscoring their dedication to excellence.

Keep Updated

For ongoing updates and insights related to this investigation, you can follow the Rosen Law Firm on various social media platforms: LinkedIn, Twitter, and Facebook. Staying informed will help investors make the best decisions regarding their involvement in this potential class action.

Conclusion

In the wake of significant market changes affecting Tandem Diabetes Care, investors are encouraged to understand their rights. With the help of the Rosen Law Firm, shareholders can pursue justice and potentially recoup losses incurred due to the alleged misleading information from the company. As the situation continues to develop, it is essential for affected investors to remain proactive in this financial landscape.